Probing the stereoselective interaction of ofloxacin enantiomers with corresponding monoclonal antibodies by multiple spectrometry

Spectrochim Acta A Mol Biomol Spectrosc. 2018 Apr 5:194:83-91. doi: 10.1016/j.saa.2018.01.008. Epub 2018 Jan 5.

Abstract

Although stereoselective antibody has immense potential in chiral compounds detection and separation, the interaction traits between stereoselective antibody and the corresponding antigenic enantiomers are not yet fully exploited. In this study, the stereospecific interactions between ofloxacin isomers and corresponding monoclonal antibodies (McAb-WR1 and McAb-MS1) were investigated using time-resolved fluorescence, steady-state fluorescence, and circular dichroism (CD) spectroscopic methods. The chiral recognition discrepancies of antibodies with ofloxacin isomers were reflected through binding constant, number of binding sites, driving forces and conformational changes. The major interacting forces of McAb-WR1 and McAb-MS1 chiral interaction systems were hydrophobic force and van der Waals forces joined up with hydrogen bonds, respectively. Synchronous fluorescence spectra and CD spectra results showed that the disturbing of tyrosine and tryptophan micro-environments were so slightly that no obvious secondary structure changes were found during the chiral hapten binding. Clarification of stereospecific interaction of antibody will facilitate the application of immunoassay to analyze chiral contaminants in food and other areas.

Keywords: Antibody; Ofloxacin isomers; Specific enantioselective interaction; Spectroscopic methods.

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / immunology
  • Anti-Bacterial Agents / metabolism
  • Antibodies, Monoclonal / immunology*
  • Binding Sites
  • Hydrogen Bonding
  • Models, Molecular
  • Ofloxacin / chemistry*
  • Ofloxacin / immunology
  • Ofloxacin / metabolism
  • Protein Binding
  • Spectrometry, Fluorescence / methods*
  • Stereoisomerism
  • Thermodynamics

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Ofloxacin